Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
Abstract Background Triple-negative breast cancer is a heterogeneous molecular subtype of BC. Pathological complete response (pCR) is an important surrogate marker for recurrence-free and overall survival. Aim of study The aim of this study was to evaluate clinical and pathological factors that are...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2023-03-01
|
| Seri Bilgileri: | Hereditary Cancer in Clinical Practice |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13053-023-00249-1 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|